Alight, Inc. / Delaware
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-04.
0001628280-26-052636
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-03.
0001628280-26-069567
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 145 previous paragraphs and 145 current paragraphs.
88 unchanged; 48 reworded; 8 added; 7 removed; 2 previous and 1 current paragraphs rearranged.
Tables are not compared: 7 previous and 7 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (8)
Current report
As of September 30, 2026, the Company concluded that the 2025 financial performance threshold specified in the Purchase Agreement had not been met, as such the Additional Seller Note will not be issued. This does not impact the issuance of the Seller Note.
Current report
Subsequent Event
Current report
On October 1, 2026, the Company acquired all of the issued and outstanding securities of Abett Inc. ("Abett"), a privately held company. The acquisition is intended to enhance Alight's benefits intelligence capabilities and will become part of our Health Solutions reporting unit. Because the acquisition closed after September 30, 2026, it is a non-recognized subsequent event; accordingly, no assets acquired or liabilities assumed have been recognized in these condensed consolidated financial statements. This acquisition will be accounted for as a business combination and is not expected to have a material impact to the Company's results of operations, financial position, or cash flows. Transaction costs associated with the acquisition were not significant.
Current report
Selling, general and administrative expenses increased $35 million, or 40.2%, for the three months ended September 30, 2026 as compared to the prior year period, primarily driven by higher severance and other restructuring costs, higher compensation expense and an increase in professional fees incurred in conjunction with debt refinancing activities.
Current report
Depreciation and intangible amortization expenses were mostly consistent with the prior year period.
Current report
(3)Goodwill impairment and other primarily includes $6 million of certain professional fees incurred in connection with our debt refinancing activities for the three and nine months ended September 30, 2026 and $1,338 million and$2,321 million non-cash goodwill impairment charges for the three and nine months ended September 30, 2025, respectively.
Current report
(2)Goodwill impairment and other primarily includes $6 million of certain professional fees incurred in connection with our debt refinancing activities for the three and nine months ended September 30, 2026 and $1,338 million and $2,321 million non-cash goodwill impairment charges for the three and nine months ended September 30, 2025, respectively.
Removed paragraphs (7)
Previous report
Goodwill impairment
Previous report
Selling, general and administrative expenses decreased $21 million, or 16.2%, for the three months ended June 30, 2026 primarily driven by lower severance and other restructuring costs.
Previous report
Goodwill Impairment
Previous report
Goodwill Impairment
Previous report
(3)Goodwill impairment and other primarily includes a $983 million non-cash goodwill impairment charge for each of the three and six months ended June 30, 2025 related to the Company's Health Solutions reporting unit.
Previous report
(2)Goodwill impairment and other primarily includes a $983 million non-cash goodwill impairment charge for each of the three and six months ended June 30, 2025 related to the Company's Health Solutions reporting unit.
Reworded paragraphs (48)
Previous wording
At Alight's 2026 Annual Meeting of Stockholders held on June 10, 2026, stockholders approved a reverse stock split of Alight's outstanding common stock and a corresponding decrease in the number of authorized shares of each class and series of common stock (the "Reverse Stock Split"). On June 10, 2026, the Company's Board of Directors determined to effectuate the Reverse Stock Split at a ratio of 1-for-20. The Reverse Stock Split became effective as of Tuesday, June 30, 2026, at 5:00 p.m. Eastern Time (the "Effective Time"). Alight’s Class A Common Stock began trading on a split-adjusted basis on the NYSE under the existing symbol (ALIT) when the market opened on Wednesday, July 1, 2026. Proportionate adjustments were also made to Alight’s outstanding equity-based awards and equity plans as well as to the outstanding limited liability company units of Alight Holdings in accordance with the terms of the applicable agreements. All issued and outstanding common stock, share price, authorized share, weighted average shares outstanding, earnings
Current wording
At Alight's 2026 Annual Meeting of Stockholders held on June 10, 2026, stockholders approved a reverse stock split of Alight's outstanding common stock and a corresponding decrease in the number of authorized shares of each class and series of common stock (the "Reverse Stock Split"). On June 10, 2026, the Company's Board of Directors determined to effectuate the Reverse Stock Split at a ratio of 1-for-20. The Reverse Stock Split became effective as of Tuesday, June 30, 2026, at 5:00 p.m. Eastern Time (the "Effective Time"). Alight’s Class A Common Stock began trading on a split-adjusted basis on the NYSE under the existing symbol (ALIT) when the market opened on Wednesday, July 1, 2026.
Previous wording
Revenues were $1,045 million for the six months ended June 30, 2026 as compared to $1,076 million for the prior year period. The decrease of $31 million, or 2.9%, was driven by lower Net Commercial Activity, partially offset by higher project revenue. The Company continues to experience the impact from prior year client losses and lower bookings, which has impacted revenue growth and is expected to continue to impact revenue growth during the remainder of fiscal year 2026.
Current wording
Revenues were $500 million for the three months ended September 30, 2026 as compared to $533 million for the prior year period. The decrease of $33 million, or 6.2%, was driven bylower Net Commercial Activity. The Company continues to experience the impact from prior year client losses and lower bookings, which has impacted revenue growth and is expected to continue to impact revenue growth during the remainder of fiscal year 2026 and fiscal year 2027.
Previous wording
Recurring revenues for thethree months ended June 30, 2026 decreased by$21 million, or 4.3%, from$492 million in the prior year period to$471 million, primarily driven by lower Net Commercial Activity.
Current wording
Recurring revenues for thethree months ended September 30, 2026 decreased by$31 million, or 6.3%, from$489 million in the prior year period to$458 million, primarily driven by lower Net Commercial Activity.
Previous wording
Cost of services, exclusive of depreciation and amortization increased $12 million, or 3.7%, for the three months ended June 30, 2026 as compared to the prior year period and was primarily attributable to higher compensation expense.
Current wording
Cost of services, exclusive of depreciation and amortization increased $7 million, or 2.1%, for the three months ended September 30, 2026 as compared to the prior year period and was primarily attributable to higher compensation expense, partially offset by savings realized in conjunction with productivity initiatives.
Previous wording
Depreciation and amortization expenses increased by$5 million, or 18.5%, as compared to the prior year period, primarily driven by capitalized software.
Current wording
Depreciation and amortization expenses increased by$3 million, or 10.7%, as compared to the prior year period, primarily driven by capitalized software.
Previous wording
There was no goodwill impairment charge recognized for the three months ended June 30, 2026 as compared to the prior year period, where we identified a goodwill impairment in the Health Solutions reporting unit and recorded a $983 million non-cash impairment charge.
Current wording
There was no goodwill impairment charge recognized for the three months ended September 30, 2026, as compared to the prior year period, where we recorded a $1,338 million non-cash impairment charge.
Previous wording
There was nogain or loss related to the change in the fair value of financial instruments for the three months ended June 30, 2026 compared to a loss of $28 million for the prior year period. We are required to remeasure the financial instruments at the end of each reporting period and reflect a gain or loss for the change in fair value of the financial instruments in the period the change occurred. Changes in the fair value are primarily due to changes in the underlying assumptions of each respective instrument, including changes in the risk-free interest rate, volatility, cost of debt, forecasts, and the closing stock price for the period. See Note 14, "Financial Instruments" within the Condensed Consolidated Financial Statements for additional information.
Current wording
There was nogain or loss related to the change in the fair value of financial instruments for the three months ended September 30, 2026 compared to a gain of $19 million for the prior year period. We are required to remeasure the financial instruments at the end of each reporting period and reflect a gain or loss for the change in fair value of the financial instruments in the period the change occurred. Changes in the fair value are primarily due to changes in the underlying assumptions of each respective instrument, including changes in the risk-free interest rate, volatility, cost of debt, forecasts, and the closing stock price for the period. See Note 14, "Financial Instruments" within the Condensed Consolidated Financial Statements for additional information.
Previous wording
The change in the fair value of the TRA resulted in a gain of $65 million for thesix months ended June 30, 2026, an increase of $97 million compared to a loss of $32 million for the prior year period. The change in fair value was due to changes in the Company's assumptions related to the timing of the utilization of tax attributes during the term of the TRA, changes in the discount rate and the passage of time.
Current wording
The change in the fair value of the TRA resulted in a gain of $15 million for the three months ended September 30, 2026, a decrease of $51 million compared to a gain of $66 million for the prior year period. The change in fair value was due to changes in the Company's assumptions related to the timing of the utilization of tax attributes during the term of the TRA, changes in the discount rate and the passage of time.
Previous wording
Interest expense increased$2 million for the three months ended June 30, 2026 as compared to the prior year period. The increase was due to higher interest expense net of swaps.
Current wording
Interest expense of $25 million increased $1 million from the prior year. The increase was due to higher interest expense net of swaps and lower interest income.
Previous wording
Under the terms of the TSA described in Note 4, "Discontinued Operations"within the Condensed Consolidated Financial Statements, the Company had provided technology infrastructure, risk and security, and various other corporate services to the Divested Business subsequent to the close. For the three months ended June 30, 2026, we recorded an immaterial amount of income for services performed under the TSA. For the three months ended June 30, 2025, we recorded $8 million for services performed under the TSA. TSA services income is recorded in Other (income) expense, net. The corresponding expenses were recognized in Cost of services, exclusive of depreciation and amortization, and Selling, general and administrative expense in the Condensed Consolidated Statement of Comprehensive Income (Loss).
Current wording
Under the terms of the TSA described in Note 4, "Discontinued Operations"within the Condensed Consolidated Financial Statements, the Company had provided technology infrastructure, risk and security, and various other corporate services to the Divested Business subsequent to the close. For the three months ended September 30, 2026, we recorded less than $1 million of income for services performed under the TSA. For the three months ended September 30, 2025, we recorded $7 million of income for services performed under the TSA. TSA services income is recorded in Other (income) expense, net. The corresponding expenses were recognized in Cost of services, exclusive of depreciation and amortization, and Selling, general and administrative expenses in the Condensed Consolidated Statements of Comprehensive Income (Loss).
Previous wording
Loss from continuing operations before taxes was $19 million for the three months ended June 30, 2026 as compared to loss from continuing operations before taxes of $1,076 million for the three months ended June 30, 2025. The decrease in loss was primarily attributable to a decrease in the non-cash goodwill impairment and the change in fair value of the TRA, partially offset by lower gross profit.
Current wording
Loss from continuing operations before taxes was $70 million for the three months ended September 30, 2026 as compared to loss from continuing operations before taxes of $1,253 million for the three months ended September 30, 2025. The decrease in loss was primarily attributable to a decrease in the non-cash goodwill impairment, partially offset by the non-operating fair value remeasurements of the tax receivable agreement and financial instruments.
Previous wording
Income tax benefit was $9 million for the three months ended June 30, 2026, as compared to an income tax benefit of $3 million for the prior year period. The effective tax rate of 47% for the three months ended June 30, 2026 was higher than the 21% U.S. statutory corporate income tax rate primarily due to the Company’s non-deductible expenses, tax credits, and changes in valuation allowance. The effective tax rate of 0% for the three months ended June 30, 2025 was lower than the 21% U.S. statutory corporate income tax rate primarily due to the Company’s non-deductible expenses, tax credits, changes in valuation allowance, and certain non-recurring items including non-deductible goodwill impairment. See Note 7, “Income Taxes” within the Condensed Consolidated Financial Statements for additional information.
Current wording
Income tax benefit was $19 million for the three months ended September 30, 2026, as compared to an income tax benefit of $198 million for the prior year period. The effective tax rate of 27% for the three months ended September 30, 2026 was higher than the 21% U.S. statutory corporate income tax rate primarily driven by changes in valuation allowance, the Company’s non-deductible expenses, and state income taxes. The effective tax rate of 16% for the three months ended September 30, 2025 was lower than the 21% U.S. statutory corporate income tax rate primarily due to the Company’s non-deductible expenses, tax credits, changes in valuation allowance, and certain non-recurring items including non-deductible goodwill impairment. See Note 7, “Income Taxes” within the Condensed Consolidated Financial Statements for additional information.
Previous wording
Results of Continuing Operations for the Six Months Ended June 30, 2026 Compared to the Six Months Ended June 30, 2025
Current wording
Results of Continuing Operations for the Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025
Previous wording
Revenues were $511 million for the three months ended June 30, 2026 as compared to $528 million for the prior year period. The decrease of $17 million, or 3.2%, was driven by lower Net Commercial Activity, partially offset by higher project revenue. The Company continues to experience the impact from prior year client losses and lower bookings, which has impacted revenue growth and is expected to continue to impact revenue growth during the remainder of fiscal year 2026.
Current wording
Revenues were $1,545 million for the nine months ended September 30, 2026 as compared to $1,609 million for the prior year period. The decrease of $64 million, or 4.0%, was driven by lower Net Commercial Activity, partially offset by higher project revenue. The Company continues to experience the impact from prior year client losses and lower bookings, which has impacted revenue growth and is expected to continue to impact revenue growth during the remainder of fiscal year 2026 and fiscal year 2027.
Previous wording
Recurring revenues for the six months ended June 30, 2026 decreased by $43 million, or 4.2%, from $1,012 million in the prior year period to $969 million, primarily driven by lower Net Commercial Activity.
Current wording
Recurring revenues for the nine months ended September 30, 2026 decreased by $74 million, or 4.9%, from $1,501 million in the prior year period to $1,427 million, primarily driven by lower Net Commercial Activity.
Previous wording
Cost of services, exclusive of depreciation and amortization increased $8 million, or 1.2%, for thesix months ended June 30, 2026 as compared to the prior year periodand was primarily attributable to higher compensation expense.
Current wording
Cost of services, exclusive of depreciation and amortization increased $15 million, or 1.5%, for thenine months ended September 30, 2026 as compared to the prior year periodand was primarily attributable to higher compensation expense, partially offset by savings realized in conjunction with productivity initiatives.
Previous wording
Depreciation and amortization expenses increased by $10 million, or 18.9%, as compared to the prior year period, primarily driven by capitalized software.
Current wording
Depreciation and amortization expenses increased by $13 million, or 16.0%, as compared to the prior year period, primarily driven by capitalized software.
Previous wording
Selling, general and administrative expenses decreased $20 million, or 8.5%, for thesix months ended June 30, 2026 and were primarily driven by lower severance and other restructuring costs.
Current wording
Selling, general and administrative expenses increased $15 million, or 4.7%, for thenine months ended September 30, 2026 and were primarily driven by an increase in compensation expense and higher restructuring costs.
Previous wording
There was no goodwill impairment charge recognized for thesix months ended June 30, 2026 as compared to the prior year period, where we identified a goodwill impairment in the Health Solutions reporting unit and recorded a $983 million non-cash impairment charge.
Current wording
There was no goodwill impairment charge recognized for the nine months ended September 30, 2026, as compared to the prior year period, where we recorded a $2,321 million non-cash impairment charge.
Previous wording
There was no gain or loss related to the change in the fair value of financial instruments for thesix months ended June 30, 2026 compared to a loss of $20 million for the prior year period. We are required to remeasure the financial instruments at the end of each reporting period and reflect a gain or loss for the change in fair value of the financial instruments in the period the change occurred. Changes in the fair value are primarily due to changes in the underlying assumptions of each respective instrument, including changes in the risk-free interest rate, volatility, cost of debt, forecasts, and the closing stock price for the period. See Note 14, "Financial Instruments" within the Condensed Consolidated Financial Statements for additional information.
Current wording
There was no gain or loss related to the change in the fair value of financial instruments for thenine months ended September 30, 2026 compared to a loss of $1 million for the prior year period. We are required to remeasure the financial instruments at the end of each reporting period and reflect a gain or loss for the change in fair value of the financial instruments in the period the change occurred. Changes in the fair value are primarily due to changes in the underlying assumptions of each respective instrument, including changes in the risk-free interest rate, volatility, cost of debt, forecasts, and the closing stock price for the period. See Note 14, "Financial Instruments" within the Condensed Consolidated Financial Statements for additional information.
Previous wording
The change in the fair value of the TRA resulted in a gain of $46 million for the three months ended June 30, 2026, an increase of $69 million compared to a loss of $23 million for the prior year period. The change in fair value was due to changes in the Company's assumptions related to the timing of the utilization of tax attributes during the term of the TRA, changes in the discount rate and the passage of time.
Current wording
The change in the fair value of the TRA resulted in a gain of $80 million for thenine months ended September 30, 2026, an increase of $46 million compared to a gain of $34 million for the prior year period. The change in fair value was due to changes in the Company's assumptions related to the timing of the utilization of tax attributes during the term of the TRA, changes in the discount rate and the passage of time.
Previous wording
Interest expense increased $4 million for the six months ended June 30, 2026 as compared to the prior year period. The increase was due to higher interest expense net of swaps and lower interest income.
Current wording
Interest expense increased $5 million for the nine months ended September 30, 2026 as compared to the prior year period. The increase was due to higher interest expense net of swaps and lower interest income.
Previous wording
Under the terms of the TSA described in Note 4, "Discontinued Operations"within the Condensed Consolidated Financial Statements, the Company had provided technology infrastructure, risk and security, and various other corporate services to the Divested Business subsequent to the close. For the six months ended June 30, 2026, we recorded $1 million of income for services performed under the TSA. For the six months ended June 30, 2025, we recorded $18 million for services performed under the TSA. TSA income is recorded in Other (income) expense, net. The corresponding expenses were recognized in Cost of services, exclusive of depreciation and amortization, and Selling, general and administrative expense in the Condensed Consolidated Statement of Comprehensive Income (Loss).
Current wording
Under the terms of the TSA described in Note 4, "Discontinued Operations"within the Condensed Consolidated Financial Statements, the Company had provided technology infrastructure, risk and security, and various other corporate services to the Divested Business subsequent to the close. For the nine months ended September 30, 2026, we recorded $1 million of income for services performed under the TSA. For the nine months ended September 30, 2025, we recorded $25 million of income for services performed under the TSA. TSA income is recorded in Other (income) expense, net. The corresponding expenses were recognized in Cost of services, exclusive of depreciation and amortization, and Selling, general and administrative expenses in the Condensed Consolidated Statements of Comprehensive Income (Loss).
Previous wording
Loss from continuing operations before taxes was $45 million for the six months ended June 30, 2026 as compared to loss from continuing operations before taxes of $1,096 million for the six months ended June 30, 2025. The decrease in loss was primarily attributable to the decrease in the non-cash goodwill impairment and the change in fair value of the TRA, partially offset by lower gross profit.
Current wording
Loss from continuing operations before taxes was $115 million for the nine months ended September 30, 2026 as compared to loss from continuing operations before taxes of $2,349 million for the nine months ended September 30, 2025. The decrease in loss was primarily attributable to the decrease in the non-cash goodwill impairment and the non-operating fair value remeasurements of the tax receivable agreement, partially offset by lower gross profit.
Previous wording
Income tax benefit was $16 million for the six months ended June 30, 2026, as compared to an income tax benefit of $6 million for the prior year period. The effective tax rate of 36% for the six months ended June 30, 2026 was higher than the 21% U.S. statutory corporate income tax rate primarily due to the Company’s non-deductible expenses, tax credits, and changes in valuation allowance. The effective tax rate of 1% for the six months ended June 30, 2025 was lower than the 21% U.S. statutory corporate income tax rate primarily due to the Company’s non-deductible expenses, tax credits, changes in valuation allowance, and certain non-recurring items including non-deductible goodwill impairment. See Note 7, “Income Taxes” within the Condensed Consolidated Financial Statements for additional information.
Current wording
Income tax benefit was $35 million for the nine months ended September 30, 2026, as compared to an income tax benefit of $204 million for the prior year period. The effective tax rate of 30% for the nine months ended September 30, 2026 was higher than the 21% U.S. statutory corporate income tax rate primarily driven by changes in valuation allowance, the Company’s non-deductible expenses, and state income taxes. The effective tax rate of 9% for the nine months ended September 30, 2025 was lower than the 21% U.S. statutory corporate income tax rate primarily due to the Company’s non-deductible expenses, tax credits, changes in valuation allowance, and certain non-recurring items including non-deductible goodwill impairment. See Note 7, “Income Taxes” within the Condensed Consolidated Financial Statements for additional information.
Previous wording
Adjusted Diluted Earnings Per Share From Continuing Operations is defined as Adjusted Net Income From Continuing Operations divided by the adjusted weighted-average number of shares of common stock, diluted. The adjusted weighted shares calculation assumes the full exchange of the non-controlling interest units and the full amount of non-vested time-based restricted units that were determined to be antidilutive and therefore excluded from the U.S. GAAP diluted earnings per share. Adjusted Diluted Earnings Per Share From Continuing Operations, including the adjusted weighted-average number of shares, is used by us and our investors to evaluate our core operating performance and to benchmark our operating performance against our competitors.
Current wording
Adjusted Diluted Earnings Per Share From Continuing Operations is defined as Adjusted Net Income From Continuing Operations divided by the adjusted weighted-average number of shares of common stock, diluted. The adjusted weighted shares calculation assumes the full exchange of the non-controlling interest units and the full amount of non-vested time-based restricted stock units that were determined to be antidilutive and therefore excluded from the U.S. GAAP diluted earnings per share. Adjusted Diluted Earnings Per Share From Continuing Operations, including the adjusted weighted-average number of shares, is used by us and our investors to evaluate our core operating performance and to benchmark our operating performance against our competitors.
Previous wording
(2)Transaction and integration expenses primarily relate to acquisitions and divestiture activities.
Current wording
(2)Transaction and integration expenses primarily relate to acquisition and divestiture activities.
Previous wording
(8)Excludes approximately 1.9 million and 0.3 million performance-based units, which represents the gross number of shares expected to vest based on achievement of the respective performance and market conditions as of June 30, 2026 and 2025, respectively.
Current wording
(8)Excludes approximately 2.1 million and 0.1 million performance-based units, which represents the gross number of shares expected to vest based on achievement of the respective performance and market conditions as of September 30, 2026 and 2025, respectively.
Previous wording
Adjusted EBITDA From Continuing Operations is defined as earnings before interest, taxes, depreciation and intangible amortization adjusted for the impact of certain non-cash and other items, including goodwill impairments, that we do not consider in the evaluation of ongoing operational performance. Adjusted EBITDA Margin From Continuing Operations is defined as Adjusted EBITDA From Continuing Operations divided by revenue. Adjusted EBITDA and Adjusted EBITDA Margin From Continuing Operations are non-GAAP financial measures used by management and our stakeholders to provide useful supplemental information that enables a better comparison of our performance across periods as well as to evaluate our core operating performance. A reconciliation of Adjusted EBITDA From Continuing Operations to Net Income (Loss) From Continuing Operations is as follows:
Current wording
Adjusted EBITDA From Continuing Operations is defined as earnings before interest, taxes, depreciation and intangible amortization adjusted for the impact of certain non-cash and other items, including goodwill impairments, that we do not consider in the evaluation of ongoing operational performance. Adjusted EBITDA Margin From Continuing Operations is defined as Adjusted EBITDA From Continuing Operations divided by revenue. Adjusted EBITDA From Continuing Operations and Adjusted EBITDA Margin From Continuing Operations are non-GAAP financial measures used by management and our stakeholders to provide useful supplemental information that enables a better comparison of our performance across periods as well as to evaluate our core operating performance. A reconciliation of Adjusted EBITDA From Continuing Operations to Net Income (Loss) From Continuing Operations is as follows:
Previous wording
(3)Adjusted EBITDA excludes the impact of discontinued operations.
Current wording
(3)Adjusted EBITDA From Continuing Operations excludes the impact of discontinued operations.
Previous wording
Employer Solutions Results of Operations for the Three and Six Months Ended June 30, 2026 Compared to the Three and Six Months Ended June 30, 2025
Current wording
Employer Solutions Results of Operations for the Three and Nine Months Ended September 30, 2026 Compared to the Three and Nine Months Ended September 30, 2025
Previous wording
Employer Solutions revenue was$1,045 million for the six months ended June 30, 2026 as compared to $1,076 million for the prior year period. The overall decrease of $31 million was primarily driven bydecreases in Net Commercial Activity, partially offset by an increase in project revenue.
Current wording
Employer Solutions revenue was$500 million for the three months ended September 30, 2026 as compared to$533 million for the prior year period. The overall decrease of $33 million was primarily driven bydecreases in Net Commercial Activity.
Previous wording
Employer Solutions revenue was$511 million for the three months ended June 30, 2026 as compared to$528 million for the prior year period. The overall decrease of $17 million was primarily driven by decreases in Net Commercial Activity, partially offset by an increase in project revenue.
Current wording
Employer Solutions revenue was$1,545 million for the nine months ended September 30, 2026 as compared to $1,609 million for the prior year period. The overall decrease of $64 million was primarily driven by decreases in Net Commercial Activity, partially offset by an increase in project revenue.
Previous wording
Gross Profit to Adjusted Gross Profit Reconciliation for the Three and Six Months Ended June 30, 2026 Compared to the Three and Six Months Ended June 30, 2025
Current wording
Gross Profit to Adjusted Gross Profit Reconciliation for the Three and Nine Months Ended September 30, 2026 Compared to the Three and Nine Months Ended September 30, 2025
Previous wording
Employer Solutions gross profit was $142 million for the three months ended June 30, 2026 compared to $176 million for the prior year period. The decrease of $34 million was primarily driven by lower revenues. Employer Solutions adjusted gross profit decreased $29 million for the three months ended June 30, 2026 to $176 million from $205 million in the prior year period, primarily driven by lower revenues.
Current wording
Employer Solutions gross profit was $135 million for the three months ended September 30, 2026 compared to $178 million for the prior year period. The decrease of $43 million was primarily driven by lower revenues and an increase in compensation expense. Employer Solutions adjusted gross profit decreased $38 million for the three months ended September 30, 2026 to $168 million from $206 million in the prior year period, primarily attributable to lower revenues and an increase in compensation expense.
Previous wording
Employer Solutions gross profit was $298 million for the six months ended June 30, 2026 compared to $347 million for the prior year period. The decrease of $49 million was driven by lower revenues. Employer Solutions adjusted gross profit decreased $40 million for the six months ended June 30, 2026 to $365 million from $405 million in the prior year period, primarily driven by lower revenues.
Current wording
Employer Solutions gross profit was $433 million for the nine months ended September 30, 2026 compared to $525 million for the prior year period. The decrease of $92 million was driven primarily by lower revenues and an increase in compensation expense. Employer Solutions adjusted gross profit decreased $78 million for the nine months ended September 30, 2026 to $533 million from $611 million in the prior year period, primarily driven by lower revenues and an increase in compensation expense.
Previous wording
Cash provided by operating activities - continuing operations was $152 million for the six months ended June 30, 2026 as compared to $159 million for the six months ended June 30, 2025. The decrease in cash provided by operating activities - continuing operations was primarily due to lower gross profit partially offset by changes in our net working capital requirements.
Current wording
Cash provided by operating activities - continuing operations was $181 million for the nine months ended September 30, 2026 as compared to $236 million for the nine months ended September 30, 2025. The decrease in cash provided by operating activities - continuing operations was primarily due to lower gross profit, partially offset by changes in our net working capital requirements.
Previous wording
Free cash flow was $101 million for the six months ended June 30, 2026 and was consistent with the prior year period primarily due to a decrease in cash provided from operations, offset by lower capital expenditures.
Current wording
Free cash flow was $108 million for the nine months ended September 30, 2026 compared to $151 million for the prior year period. The decrease in free cash flow was primarily due to a decrease in cash provided from operations, partially offset by lower capital expenditures.
Previous wording
As of June 30, 2026, we had outstanding long-term debt in the form of term loans for an aggregate principal amount of $1,976 million, which will mature in 2028. In addition, we have a $330 million revolving credit facility with a maturity date of May 31, 2030. As of June 30, 2026, no amounts were borrowed or outstanding under our revolving credit facility agreement.
Current wording
As of September 30, 2026, we had total outstanding debt in the form of term loans for an aggregate principal amount of $1,994 million, which will mature in 2028. In addition, we have a $330 million revolving credit facility with a maturity date of May 31, 2030. As of September 30, 2026, no amounts were borrowed or outstanding under our revolving credit facility agreement.
Previous wording
During the three and six months ended June 30, 2026, the Company did not repurchase any shares of Class A Common Stock. As of June 30, 2026, the total remaining amount authorized for repurchase was $216 million.
Current wording
During the three and nine months ended September 30, 2026, the Company did not repurchase any shares of Class A Common Stock. As of September 30, 2026, the total remaining amount authorized for repurchase was $216 million.
Showing the first 40 of 48 pairs. Open the source sections for the rest.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
Proportionate adjustments were also made to Alight’s outstanding equity-based awards and equity plans as well as to the outstanding limited liability company units of Alight Holdings in accordance with the terms of the applicable agreements. All issued and outstanding common stock, share price, authorized share, weighted average shares outstanding, earnings (loss) per share, share-based compensation awards, outstanding Alight Holdings units and per share amounts contained in this Quarterly Report on Form 10-Q have been adjusted retroactively to reflect the Reverse Stock Split for all periods presented.
Rearranged previous paragraphs (2)
Previous report — wording carried elsewhere
(loss) per share, share-based compensation awards, outstanding Alight Holdings units and per share amounts contained in this Quarterly Report on Form 10-Q have been adjusted retroactively to reflect the Reverse Stock Split for all periods presented.
Previous report — wording carried elsewhere
Depreciation and intangible amortization expenses were consistent with the prior year period.